Form 4 for LRCX Lam Research
Accepted 2022-02-02 00:00:00 ET · period of report 2022-02-01 · accession 0000707549-22-000016 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-02-02 | 2022-02-01 | LRCX | Meikle Scott Gerald | SVP | M - OptEx | $188.70 | +700 | 17.1K | +4% | +$132.1K |
| DM | 2022-02-02 | 2022-02-01 | LRCX | Meikle Scott Gerald | SVP | S - Sale+OE | $590.00 | -700 | 17.0K | -4% | -$413.0K |
| DM | 2022-02-02 | 2022-02-01 | LRCX | Meikle Scott Gerald | SVP | M - OptEx | $188.70 | -700 | 6,300 | -10% | -$132.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-01 | M | A | 628 | $190.07 | 17,652 | D | — | — | (F1) This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 11, 2021. (F2) The amount reported includes shares subject to unvested Restricted Stock Units. |
| 2 | Common | Common Stock | 2022-02-01 | M | A | 72 | $176.75 | 17,096 | D | — | — | (F1) This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 11, 2021. (F2) The amount reported includes shares subject to unvested Restricted Stock Units. |
| 3 | Common | Common Stock | 2022-02-01 | S | D | 628 | $590.00 | 17,024 | D | — | — | (F1) This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 11, 2021. (F2) The amount reported includes shares subject to unvested Restricted Stock Units. |
| 4 | Common | Common Stock | 2022-02-01 | S | D | 72 | $590.00 | 17,024 | D | — | — | (F1) This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 11, 2021. (F2) The amount reported includes shares subject to unvested Restricted Stock Units. |
| 5 | Derivative | Employee Stock Option (Right to Buy) | 2022-02-01 | M | D | 628 | $190.07 | 0 | D | $190.07 · — to 2025-03-01 | 628 Common Stock | (F3) The stock options will become exercisable in three equal installments on 03/02/2019, 03/02/2020, and 03/02/2021. |
| 6 | Derivative | Employee Stock Option (Right to Buy) | 2022-02-01 | M | D | 72 | $176.75 | 6,300 | D | $176.75 · — to 2026-03-01 | 72 Common Stock | (F4) The stock options will become exercisable in three equal installments on 03/02/2020, 03/02/2021, and 03/02/2022. |